These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 33328453)

  • 1. Genetic architecture of host proteins involved in SARS-CoV-2 infection.
    Pietzner M; Wheeler E; Carrasco-Zanini J; Raffler J; Kerrison ND; Oerton E; Auyeung VPW; Luan J; Finan C; Casas JP; Ostroff R; Williams SA; Kastenmüller G; Ralser M; Gamazon ER; Wareham NJ; Hingorani AD; Langenberg C
    Nat Commun; 2020 Dec; 11(1):6397. PubMed ID: 33328453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic architecture of host proteins interacting with SARS-CoV-2.
    Pietzner M; Wheeler E; Carrasco-Zanini J; Raffler J; Kerrison ND; Oerton E; Auyeung VPW; Luan J; Finan C; Casas JP; Ostroff R; Williams SA; Kastenmüller G; Ralser M; Gamazon ER; Wareham NJ; Hingorani AD; Langenberg C
    bioRxiv; 2020 Jul; ():. PubMed ID: 32637948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lung expression of genes putatively involved in SARS-CoV-2 infection is modulated in cis by germline variants.
    Cotroneo CE; Mangano N; Dragani TA; Colombo F
    Eur J Hum Genet; 2021 Jun; 29(6):1019-1026. PubMed ID: 33649539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a special cell type as a determinant of the kidney tropism of SARS-CoV-2.
    Lin H; Ma X; Xiao F; Su H; Shi Y; Liu Y; Song L; Zhang Z; Zhang C; Peng H
    FEBS J; 2021 Sep; 288(17):5163-5178. PubMed ID: 34228902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Where all the Roads Meet? A Crossover Perspective on Host Factors Regulating SARS-CoV-2 infection.
    Lata S; Mishra R; Arya RP; Arora P; Lahon A; Banerjea AC; Sood V
    J Mol Biol; 2022 Mar; 434(5):167403. PubMed ID: 34914966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA aptamers masking angiotensin converting enzyme 2 as an innovative way to treat SARS-CoV-2 pandemic.
    Villa A; Brunialti E; Dellavedova J; Meda C; Rebecchi M; Conti M; Donnici L; De Francesco R; Reggiani A; Lionetti V; Ciana P
    Pharmacol Res; 2022 Jan; 175():105982. PubMed ID: 34798263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Host PDZ-containing proteins targeted by SARS-CoV-2.
    Caillet-Saguy C; Durbesson F; Rezelj VV; Gogl G; Tran QD; Twizere JC; Vignuzzi M; Vincentelli R; Wolff N
    FEBS J; 2021 Sep; 288(17):5148-5162. PubMed ID: 33864728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactomes of SARS-CoV-2 and human coronaviruses reveal host factors potentially affecting pathogenesis.
    Chen Z; Wang C; Feng X; Nie L; Tang M; Zhang H; Xiong Y; Swisher SK; Srivastava M; Chen J
    EMBO J; 2021 Sep; 40(17):e107776. PubMed ID: 34232536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of microRNAs in modulating SARS-CoV-2 infection in human cells: a systematic review.
    Marchi R; Sugita B; Centa A; Fonseca AS; Bortoletto S; Fiorentin K; Ferreira S; Cavalli LR
    Infect Genet Evol; 2021 Jul; 91():104832. PubMed ID: 33812037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ABO phenotype and SARS-CoV-2 infection: Is there any correlation?
    Mathew A; Vignesh Balaji E ; Pai SRK; Kishore A; Pai V; Chandrashekar KS
    Infect Genet Evol; 2021 Jun; 90():104751. PubMed ID: 33540085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide bioinformatic analyses predict key host and viral factors in SARS-CoV-2 pathogenesis.
    Ferrarini MG; Lal A; Rebollo R; Gruber AJ; Guarracino A; Gonzalez IM; Floyd T; de Oliveira DS; Shanklin J; Beausoleil E; Pusa T; Pickett BE; Aguiar-Pulido V
    Commun Biol; 2021 May; 4(1):590. PubMed ID: 34002013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age- and airway disease related gene expression patterns of key SARS-CoV-2 entry factors in human nasal epithelia.
    Plaas M; Seppa K; Gaur N; Kasenõmm P; Plaas M
    Virology; 2021 Sep; 561():65-68. PubMed ID: 34157565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 early infection signature identified potential key infection mechanisms and drug targets.
    Li Y; Duche A; Sayer MR; Roosan D; Khalafalla FG; Ostrom RS; Totonchy J; Roosan MR
    BMC Genomics; 2021 Feb; 22(1):125. PubMed ID: 33602138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential Co-Expression Network Analysis Reveals Key Hub-High Traffic Genes as Potential Therapeutic Targets for COVID-19 Pandemic.
    Hasankhani A; Bahrami A; Sheybani N; Aria B; Hemati B; Fatehi F; Ghaem Maghami Farahani H; Javanmard G; Rezaee M; Kastelic JP; Barkema HW
    Front Immunol; 2021; 12():789317. PubMed ID: 34975885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular host factors for SARS-CoV-2 infection.
    Baggen J; Vanstreels E; Jansen S; Daelemans D
    Nat Microbiol; 2021 Oct; 6(10):1219-1232. PubMed ID: 34471255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computational Identification of Human Biological Processes and Protein Sequence Motifs Putatively Targeted by SARS-CoV-2 Proteins Using Protein-Protein Interaction Networks.
    Nadeau R; Shahryari Fard S; Scheer A; Hashimoto-Roth E; Nygard D; Abramchuk I; Chung YE; Bennett SAL; Lavallée-Adam M
    J Proteome Res; 2020 Nov; 19(11):4553-4566. PubMed ID: 33103435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional prediction and comparative population analysis of variants in genes for proteases and innate immunity related to SARS-CoV-2 infection.
    Klaassen K; Stankovic B; Zukic B; Kotur N; Gasic V; Pavlovic S; Stojiljkovic M
    Infect Genet Evol; 2020 Oct; 84():104498. PubMed ID: 32771700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological inhibition of fatty acid synthesis blocks SARS-CoV-2 replication.
    Chu J; Xing C; Du Y; Duan T; Liu S; Zhang P; Cheng C; Henley J; Liu X; Qian C; Yin B; Wang HY; Wang RF
    Nat Metab; 2021 Nov; 3(11):1466-1475. PubMed ID: 34580494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated temperature inhibits SARS-CoV-2 replication in respiratory epithelium independently of IFN-mediated innate immune defenses.
    Herder V; Dee K; Wojtus JK; Epifano I; Goldfarb D; Rozario C; Gu Q; Da Silva Filipe A; Nomikou K; Nichols J; Jarrett RF; Stevenson A; McFarlane S; Stewart ME; Szemiel AM; Pinto RM; Masdefiol Garriga A; Davis C; Allan J; Graham SV; Murcia PR; Boutell C
    PLoS Biol; 2021 Dec; 19(12):e3001065. PubMed ID: 34932557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic variation analyses indicate conserved SARS-CoV-2-host interaction and varied genetic adaptation in immune response factors in modern human evolution.
    Lee JW; Lee IH; Sato T; Kong SW; Iimura T
    Dev Growth Differ; 2021 Apr; 63(3):219-227. PubMed ID: 33595856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.